Clinical Trial Update: Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Lactoserum (Dermacyd Femina) for preventing recurrence of Bacterial Vaginosis; study sponsored by Sanofi and status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• Lactoserum (lactoserum)

Snippet

Sponsor: Sanofi | Conditions: Bacterial Vaginosis | Phase 4 | Status: COMPLETED